Kinase Inhibitor News and Research

RSS
A protein kinase inhibitor is a type of enzyme inhibitor that specifically blocks the action of one or more protein kinases.
Cancer drug shows promise in battling Parkinson’s disease

Cancer drug shows promise in battling Parkinson’s disease

Study shows nilotinib drug is safe and well tolerated in patients with Parkinson's disease

Study shows nilotinib drug is safe and well tolerated in patients with Parkinson's disease

Modifying a cancer drug has created a new agent for multi-resistant infections

Modifying a cancer drug has created a new agent for multi-resistant infections

Treatment combination improves survival in advanced HER2-positive breast cancer patients

Treatment combination improves survival in advanced HER2-positive breast cancer patients

Scientists highlight the benefits of Droplet Digital PCR technology at the 2019 ASH meeting

Scientists highlight the benefits of Droplet Digital PCR technology at the 2019 ASH meeting

New strategies needed to manage ibrutinib-related toxicities in CLL patients, study suggests

New strategies needed to manage ibrutinib-related toxicities in CLL patients, study suggests

Relapsed mantle cell lymphoma patients may benefit from CAR T-cell therapy

Relapsed mantle cell lymphoma patients may benefit from CAR T-cell therapy

Ibrutinib-based therapy provides superior clinical outcomes in majority of CLL patients

Ibrutinib-based therapy provides superior clinical outcomes in majority of CLL patients

Juvenile immune arthritis – new treatments wanted

Juvenile immune arthritis – new treatments wanted

UCLA researchers discover new way to eliminate leukemia stem cells

UCLA researchers discover new way to eliminate leukemia stem cells

RTKI drugs may not significantly improve survival rates of patients during radiotherapy

RTKI drugs may not significantly improve survival rates of patients during radiotherapy

Study may help in personalizing treatment for lung cancer, develop new drugs

Study may help in personalizing treatment for lung cancer, develop new drugs

Researchers find new target for disease of the heart's smallest blood vessels

Researchers find new target for disease of the heart's smallest blood vessels

New drug combinations and dosing schedules improve outlook in advanced colon cancer

New drug combinations and dosing schedules improve outlook in advanced colon cancer

Study suggests usefulness of more flexible dose of regorafenib to relieve side-effects in mCRC patients

Study suggests usefulness of more flexible dose of regorafenib to relieve side-effects in mCRC patients

Still-to-be-approved drug proves to be new option for treating active rheumatoid arthritis

Still-to-be-approved drug proves to be new option for treating active rheumatoid arthritis

Researchers discover unique approach to treat some chronic inflammatory diseases

Researchers discover unique approach to treat some chronic inflammatory diseases

Scientists use a promiscuous inhibitor to uncover cancer drug targets

Scientists use a promiscuous inhibitor to uncover cancer drug targets

FDA extends indication of metastatic breast cancer treatment to include male patients

FDA extends indication of metastatic breast cancer treatment to include male patients

Understanding maintenance of quiescent stem cells in chronic myelogenous leukemia

Understanding maintenance of quiescent stem cells in chronic myelogenous leukemia